Inventor · Leiden, NL

Rienk Offringa

13Patents
3h-index
47Co-inventors
60Inventor score

Filing activity: Sep 21, 2000 → Nov 30, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7807369B2 Methods and means for the treatment of HPV induced intraepithelial neoplasia Chemistry; Metallurgy 9 Expired
US7202034B2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Chemistry; Metallurgy 7 Expired
US7563445B2 CD40 binding molecules and CTL peptides for treating tumors Chemistry; Metallurgy 3 Expired
US7892828B2 Method of identifying a MHC class I restricted T cell response Human Necessities 1 Active
US7560105B1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses Chemistry; Metallurgy 1 Expired
US9650423B2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Chemistry; Metallurgy 1 Active
US11998539B2 Substituted aminoquinolones as DGKalpha inhibitors for immune activation Chemistry; Metallurgy 0 Active
US9115185B2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Chemistry; Metallurgy 0 Active
US11427578B1 Substituted pyrrolopyridine-derivatives Human Necessities 0 Active
US8663646B2 P53 peptide vaccine Chemistry; Metallurgy 0 Active
US12221479B2 Pharmaceutical combination of anti CEACAM6 and TIM3 antibodies Chemistry; Metallurgy 0 Active
US10253073B2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Chemistry; Metallurgy 0 Active
US11964953B2 Substituted aminothiazoles as DGKzeta inhibitors for immune activation Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.